These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22480983)

  • 1. Changes of metabolic and inflammatory markers in HIV infection: glucose, lipids, serum Hs-CRP and myeloperoxidase.
    Borato DC; Parabocz GC; Ribas SR; Kalva-Filho CA; Borba LM; Ito CA; Bail L; dos Santos FA; Vellosa JC
    Metabolism; 2012 Oct; 61(10):1353-60. PubMed ID: 22480983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between dyslipidemia and insulin resistance in HIV-infected persons treated with highly active antiretroviral therapy.
    Swanson B; Keithley JK; Zeller JM; Sha BE
    Nutrition; 2004; 20(11-12):1022-5. PubMed ID: 15561494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
    Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
    Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
    Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men.
    Floris-Moore M; Howard AA; Lo Y; Schoenbaum EE; Arnsten JH; Klein RS
    AIDS Patient Care STDS; 2007 Jul; 21(7):479-91. PubMed ID: 17651029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitivity C-reactive protein levels in HIV-infected patients treated or not with antiretroviral drugs and their correlation with factors related to cardiovascular risk and HIV infection.
    Guimarães MM; Greco DB; Figueiredo SM; Fóscolo RB; Oliveira AR; Machado LJ
    Atherosclerosis; 2008 Dec; 201(2):434-9. PubMed ID: 18359028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
    Verit FF
    Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study on the correlation between high sensitivity C-reactive protein and risk factors in cerebral vessel [corrected] disease].
    Zhou WJ; Tong JJ; Ye J; Lu YM
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jun; 19(6):325-8. PubMed ID: 17577433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of C-reactive protein as a marker for cardiovascular risk associated with antiretroviral therapy in HIV-infected patients.
    Masiá M; Bernal E; Padilla S; Graells ML; Jarrín I; Almenar MV; Molina J; Hernández I; Gutiérrez F
    Atherosclerosis; 2007 Nov; 195(1):167-71. PubMed ID: 17049532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy.
    Riddler SA; Li X; Chu H; Kingsley LA; Dobs A; Evans R; Palella F; Visscher B; Chmiel JS; Sharrett A
    HIV Med; 2007 Jul; 8(5):280-7. PubMed ID: 17561873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women.
    Floris-Moore M; Howard AA; Lo Y; Arnsten JH; Santoro N; Schoenbaum EE
    HIV Med; 2006 Oct; 7(7):421-30. PubMed ID: 16925727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipids, biomarkers, and subclinical atherosclerosis in treatment-naive HIV patients starting or not starting antiretroviral therapy: Comparison with a healthy control group in a 2-year prospective study.
    Di Yacovo S; Saumoy M; Sánchez-Quesada JL; Navarro A; Sviridov D; Javaloyas M; Vila R; Vernet A; Low H; Peñafiel J; García B; Ordoñez-Llanos J; Podzamczer D
    PLoS One; 2020; 15(8):e0237739. PubMed ID: 32817629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metformin and rosiglitazone on lipid metabolism in HIV infected patients receiving protease inhibitor containing HAART.
    Tomazic J; Karner P; Vidmar L; Maticic M; Sharma PM; Janez A
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):99-105. PubMed ID: 16200335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in dyslipidaemia after switching stavudine to tenofovir and replacing protease inhibitors with efavirenz in HIV-infected children.
    Viganò A; Aldrovandi GM; Giacomet V; Merlo M; Martelli L; Beretta S; Luraschi P; Rombolà G; Mora S
    Antivir Ther; 2005; 10(8):917-24. PubMed ID: 16430197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine concentrations decrease in patients with HIV infection under antiretroviral therapy.
    Kurz K; Teerlink T; Sarcletti M; Weiss G; Zangerle R; Fuchs D
    Antivir Ther; 2012; 17(6):1021-7. PubMed ID: 22892398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients.
    Bastard JP; Soulié C; Fellahi S; Haïm-Boukobza S; Simon A; Katlama C; Calvez V; Marcelin AG; Capeau J
    Antivir Ther; 2012; 17(5):915-9. PubMed ID: 22436412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes of neutrophil myeloperoxidase in coronary circulation among patients with acute coronary syndrome].
    Li L; Zhang Y; Chen YG; Li GS; Wang Y; Ma X; Li JF; Zhong M; Zhang W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1106-8. PubMed ID: 16563281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians.
    Muhammad S; Sani MU; Okeahialam BN
    Ann Afr Med; 2013; 12(1):24-8. PubMed ID: 23480991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.